Back to Search Start Over

COX-2 inhibitors continue to come under fire

Authors :
Walsh, Nancy
Source :
Internal Medicine News. Dec 1, 2004, Vol. 37 Issue 23, p7, 1 p.
Publication Year :
2004

Abstract

As the fallout from the rofecoxib withdrawal escalated--with Merck & Co. facing questions from federal prosecutors and the Securities and Exchange Commission--a larger question emerged: Is the cardiovascular risk a [...]

Subjects

Subjects :
Company business planning
United States. Food and Drug Administration -- Planning
Cardiovascular diseases -- Risk factors
Cyclooxygenases
COX-2 inhibitors
Antiarthritic agents
Medical research
Medicine, Experimental

Details

Language :
English
ISSN :
10978690
Volume :
37
Issue :
23
Database :
Gale General OneFile
Journal :
Internal Medicine News
Publication Type :
Periodical
Accession number :
edsgcl.127051109

Tools

Authors Abstract Subjects Details